$ACTU
Actuate Therapeutics, Inc. Common stock
XNAS•Health Care•Pharmaceutical Preparations
$0.441
▼-5.43%-$0.025
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateActuate Therapeutics, Inc. Common stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ACTU down today? It is at $0.441 (-5.43%), and our scanner flagged it 13 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACTU spikes, and full due diligence on ACTU — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACTU 13 times in the last 30 days. Create a free account to track $ACTU, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ACTU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACTU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystACTUATE THERAPEUTICS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Schmitt Daniel M Officer | Sold (automatic/other) | -121K 0.5% of company | sold 29% | 302K | $122K at $1.01 | Aug 14, 26 |
Schmitt Daniel M Officer | Other | 272K 1.1% of company | added 100% | 422K | n/a | Aug 14, 26 |
Schmitt Daniel M Officer | Sold (automatic/other) | -122K 0.5% of company | sold 45% | 150K | $528K at $4.33 | Feb 13, 26 |
Schmitt Daniel M Officer | Other | 272K 1.1% of company | n/a | 272K | n/a | Feb 13, 26 |
Thomson Todd S Director | Sold (automatic/other) | -280K 1.2% of company | sold 11% | 2.35M | $1.6M at $5.80 | Jan 5, 26 |
Fletcher Aaron G.L. Director | Bought (open market) | +71K 0.3% of company | added 0.7% | 10.20M | $500K at $7.00 | Jun 27, 25 |
Kreis Leslie W. Director | Bought (open market) | +71K 0.3% of company | added 0.7% | 10.20M | $500K at $7.00 | Jun 27, 25 |
Bios Equity Cof, Lp Director | Bought (open market) | +71K 0.3% of company | added 0.7% | 10.20M | $500K at $7.00 | Jun 27, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ACTU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACTU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ACTU last traded at $0.441, down 5.43% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Actuate Therapeutics, Inc. Common stock (ACTU) is next expected to report earnings on Thursday, November 12, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ACTU Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACTU 13 times in the last 30 days.
ACTU (Actuate Therapeutics, Inc. Common stock) trades on XNAS, with a market cap of about $11M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACTU for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACTU discussion
Sign in to ask a question or join the discussion.